Jeff Yass’s Health Catalyst HCAT Stock Holding History

Jeff Yass’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$109K	Buy	54,600 +1,900	+4%	+$2.74K	﹤0.01%	12442
2026 Q1	$66.9K	Buy	+52,700	New	+$99.1K	﹤0.01%	12535
2025 Q2	–	Sell	-16,000	Closed	-$72.5K	–	13075
2025 Q1	$72.5K	Buy	16,000 +700	+5%	+$3.7K	﹤0.01%	11727
2024 Q4	$108K	Buy	+15,300	New	+$122K	﹤0.01%	11280
2022 Q4	–	Sell	-52,300	Closed	-$507K	–	12914
2022 Q3	$507K	Buy	+52,300	New	+$692K	﹤0.01%	8449
2021 Q4	–	Sell	-29,900	Closed	-$1.5M	–	13420
2021 Q3	$1.5M	Buy	29,900 +22,300	+293%	+$1.22M	﹤0.01%	6494
2021 Q2	$422K	Buy	7,600 +600	+9%	+$32K	﹤0.01%	9987
2021 Q1	$327K	Buy	+7,000	New	+$339K	﹤0.01%	10420
2020 Q4	–	Sell	-10,900	Closed	-$399K	–	11284
2020 Q3	$399K	Sell	10,900 -11,200	-51%	-$380K	﹤0.01%	8138
2020 Q2	$645K	Buy	+22,100	New	+$611K	﹤0.01%	6823

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

CDC Financial Chicago, Illinois $239M AUM

PVM

Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jeff Yass's HCAT Position: Q2 2026 in Review

Jeff Yass increased its Health Catalyst (HCAT) stake by 439% in Q2 2026, buying an estimated $514K and bringing the position to 437,227 shares worth $870K. The position accounts for ﹤0.01% of the portfolio, ranked #8554.

Jeff Yass first reported a position in HCAT in Q1 2020 and has held it in 22 quarters since. The position peaked at $1.09M in Q3 2024. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

Jeff Yass held 437,227 shares of Health Catalyst worth $870K as of Q2 2026.
Jeff Yass bought 356,073 Health Catalyst shares in Q2 2026, an estimated $514K.
Health Catalyst made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #8554 holding.
Jeff Yass first reported a position in Health Catalyst in Q1 2020 and has held it in 22 quarters since.
Jeff Yass's Health Catalyst position peaked at $1.09M in Q3 2024.
127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.